175 related articles for article (PubMed ID: 38309505)
1. The P53-P21-RB1 pathway promotes BRD4 degradation in liver cancer through USP1.
Li N; Zhang E; Li Z; Lv S; Zhao X; Ke Q; Zou Q; Li W; Wang Y; Guo H; Song T; Sun L
J Biol Chem; 2024 Mar; 300(3):105707. PubMed ID: 38309505
[TBL] [Abstract][Full Text] [Related]
2. Bromodomain Protein BRD4-Mediated Mutant p53 Transcription Promotes TNBC Progression.
Zhou JX; Agborbesong E; Li LX; Li X
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499487
[No Abstract] [Full Text] [Related]
3. Integrative analyses reveal outcome-associated and targetable molecular partnerships between TP53, BRD4, TNFRSF10B, and CDKN1A in diffuse large B-cell lymphoma.
Forberg AL; Unrau J; Weber KS; Rutz AC; Lund S; Guidinger J; Pelzel A; Hauge J; Hemmen AJ; Hartert KT
Ann Hematol; 2024 Jan; 103(1):199-209. PubMed ID: 37792064
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression.
Tan Y; Wang L; Du Y; Liu X; Chen Z; Weng X; Guo J; Chen H; Wang M; Wang X
Int J Oncol; 2018 Dec; 53(6):2503-2517. PubMed ID: 30272279
[TBL] [Abstract][Full Text] [Related]
5. BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1.
Stewart HJ; Horne GA; Bastow S; Chevassut TJ
Cancer Med; 2013 Dec; 2(6):826-35. PubMed ID: 24403256
[TBL] [Abstract][Full Text] [Related]
6. p53 Gain-of-Function Mutation Induces Metastasis via BRD4-Dependent CSF-1 Expression.
Efe G; Dunbar KJ; Sugiura K; Cunningham K; Carcamo S; Karaiskos S; Tang Q; Cruz-Acuña R; Resnick-Silverman L; Peura J; Lu C; Hasson D; Klein-Szanto AJ; Taylor AM; Manfredi JJ; Prives C; Rustgi AK
Cancer Discov; 2023 Dec; 13(12):2632-2651. PubMed ID: 37676642
[TBL] [Abstract][Full Text] [Related]
7. Effects of TP53 mutational status on gene expression patterns across 10 human cancer types.
Parikh N; Hilsenbeck S; Creighton CJ; Dayaram T; Shuck R; Shinbrot E; Xi L; Gibbs RA; Wheeler DA; Donehower LA
J Pathol; 2014 Apr; 232(5):522-33. PubMed ID: 24374933
[TBL] [Abstract][Full Text] [Related]
8. A deregulated m
Lu X; Peng L; Ding J; Li Y; Li Q; Rao M; Shu T; He X; Liu C; Ye J; Liu W; You H
Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2304534120. PubMed ID: 37782793
[TBL] [Abstract][Full Text] [Related]
9. The RASSF6 Tumor Suppressor Protein Regulates Apoptosis and Cell Cycle Progression via Retinoblastoma Protein.
Hossain S; Iwasa H; Sarkar A; Maruyama J; Arimoto-Matsuzaki K; Hata Y
Mol Cell Biol; 2018 Sep; 38(17):. PubMed ID: 29891515
[TBL] [Abstract][Full Text] [Related]
10. LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/BRD4 axis.
Fu Y; Liu L; Wu H; Zheng Y; Zhan H; Li L
Mol Cell Biochem; 2024 Mar; 479(3):553-566. PubMed ID: 37120495
[TBL] [Abstract][Full Text] [Related]
11. USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells.
Liao Y; Shao Z; Liu Y; Xia X; Deng Y; Yu C; Sun W; Kong W; He X; Liu F; Guo Z; Chen G; Tang D; Gan H; Liu J; Huang H
J Exp Clin Cancer Res; 2021 Jun; 40(1):201. PubMed ID: 34154657
[TBL] [Abstract][Full Text] [Related]
12. Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.
Dixit U; Liu Z; Pandey AK; Kothari R; Pandey VN
BMC Cancer; 2014 Dec; 14():925. PubMed ID: 25487856
[TBL] [Abstract][Full Text] [Related]
13. Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting.
Wu SY; Lee AY; Lai HT; Zhang H; Chiang CM
Mol Cell; 2013 Mar; 49(5):843-57. PubMed ID: 23317504
[TBL] [Abstract][Full Text] [Related]
14. Ionizing Radiation Combined with PARP1 Inhibitor Reduces Radioresistance in Prostate Cancer with RB1/TP53 Loss.
Fan Y; Fan H; Quan Z; Wu X
Cancer Invest; 2021 May; 39(5):423-434. PubMed ID: 33683975
[TBL] [Abstract][Full Text] [Related]
15. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation.
Wu SY; Chiang CM
J Biol Chem; 2007 May; 282(18):13141-5. PubMed ID: 17329240
[TBL] [Abstract][Full Text] [Related]
16. NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma.
Zhong XP; Kan A; Ling YH; Lu LH; Mei J; Wei W; Li SH; Guo RP
Cell Death Dis; 2019 May; 10(5):369. PubMed ID: 31068575
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the 'Fingers' subdomain of the deubiquitinase USP1 modulate its function and activity.
Olazabal-Herrero A; García-Santisteban I; Rodríguez JA
FEBS J; 2016 Mar; 283(5):929-46. PubMed ID: 26758085
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of BRD4 in Gastric Cancer and its Clinical Significance as a Novel Therapeutic Target.
Zhang M; Huang H; Wei M; Sun M; Deng G; Hu S; Wang H; Gong Y
Curr Cancer Drug Targets; 2024; 24(2):167-177. PubMed ID: 37282642
[TBL] [Abstract][Full Text] [Related]
19. BRD4 regulates cellular senescence in gastric cancer cells via E2F/miR-106b/p21 axis.
Dong X; Hu X; Chen J; Hu D; Chen LF
Cell Death Dis; 2018 Feb; 9(2):203. PubMed ID: 29434197
[TBL] [Abstract][Full Text] [Related]
20. Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response.
Park DE; Cheng J; Berrios C; Montero J; Cortés-Cros M; Ferretti S; Arora R; Tillgren ML; Gokhale PC; DeCaprio JA
Proc Natl Acad Sci U S A; 2019 Jan; 116(3):1027-1032. PubMed ID: 30598450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]